Cargando…
Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial
BACKGROUND: More information is needed about time between sexual initiation and human papillomavirus (HPV) infection and development of cervical precancer. METHODS: The objectives were to investigate the time between first sexual activity and detection of first cervical HPV infection or development...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251672/ https://www.ncbi.nlm.nih.gov/pubmed/25927224 http://dx.doi.org/10.1186/s12879-014-0551-y |
_version_ | 1782347079611318272 |
---|---|
author | Castellsagué, Xavier Paavonen, Jorma Jaisamrarn, Unnop Wheeler, Cosette M Skinner, S Rachel Lehtinen, Matti Naud, Paulo Chow, Song-Nan Del Rosario-Raymundo, Maria Rowena Teixeira, Julio C Palmroth, Johanna de Carvalho, Newton S Germar, Maria Julieta V Peters, Klaus Garland, Suzanne M Szarewski, Anne Poppe, Willy AJ Romanowski, Barbara Schwarz, Tino F Tjalma, Wiebren AA Bosch, F Xavier Bozonnat, Marie-Cecile Struyf, Frank Dubin, Gary Rosillon, Dominique Baril, Laurence |
author_facet | Castellsagué, Xavier Paavonen, Jorma Jaisamrarn, Unnop Wheeler, Cosette M Skinner, S Rachel Lehtinen, Matti Naud, Paulo Chow, Song-Nan Del Rosario-Raymundo, Maria Rowena Teixeira, Julio C Palmroth, Johanna de Carvalho, Newton S Germar, Maria Julieta V Peters, Klaus Garland, Suzanne M Szarewski, Anne Poppe, Willy AJ Romanowski, Barbara Schwarz, Tino F Tjalma, Wiebren AA Bosch, F Xavier Bozonnat, Marie-Cecile Struyf, Frank Dubin, Gary Rosillon, Dominique Baril, Laurence |
author_sort | Castellsagué, Xavier |
collection | PubMed |
description | BACKGROUND: More information is needed about time between sexual initiation and human papillomavirus (HPV) infection and development of cervical precancer. METHODS: The objectives were to investigate the time between first sexual activity and detection of first cervical HPV infection or development of first cervical intraepithelial neoplasia (CIN), and associated factors in women from the double-blind, multinational, 4-year PATRICIA trial. PATRICIA enroled women aged 15-25 years with no more than 6 lifetime sexual partners. Women were randomized 1:1 to the HPV-16/18 AS04-adjuvanted vaccine or to control, but only women from the control arm who began sexual intercourse during the study or within 6 months before enrolment, and had no HPV infection detected before the recorded date of their first sexual intercourse, were included in the present analysis. The time between onset of sexual activity and detection of the first cervical HPV infection or development of the first CIN lesion was analyzed using Kaplan-Meier and univariate and multivariable Cox proportional-hazards models. RESULTS: A total of 9337 women were enroled in the control arm of PATRICIA of whom 982 fulfilled the required inclusion criteria for analysis. A cumulative total of 28%, 44%, and 62% of the subjects had HPV infection within 12, 24, and 48 months, respectively. The overall incidence rate was 27.08 per 100 person-years. The most common oncogenic types associated with 6-month persistent infection were HPV-16 (incidence rate: 2.74 per 100 person-years), HPV-51 (2.70), HPV-52 (1.66), HPV-66 (1.14), and HPV-18 (1.09). Increased infection risk was associated with more lifetime sexual partners, being single, Chlamydia trachomatis history, and duration of hormone use. CIN1+ and CIN2+ lesions were most commonly associated with HPV-16, with an overall incidence rate of 1.87 and 1.07 per 100 person-years, respectively. Previous cervical HPV infection was most strongly associated with CIN development. CONCLUSIONS: More than 25% of women were infected with HPV within 1 year of beginning sexual activity. Without underestimating the value of vaccination at older ages, our findings emphasize its importance before sexual initiation. TRIAL REGISTRATION: clinicaltrials.gov: NCT00122681. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0551-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4251672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42516722014-12-03 Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial Castellsagué, Xavier Paavonen, Jorma Jaisamrarn, Unnop Wheeler, Cosette M Skinner, S Rachel Lehtinen, Matti Naud, Paulo Chow, Song-Nan Del Rosario-Raymundo, Maria Rowena Teixeira, Julio C Palmroth, Johanna de Carvalho, Newton S Germar, Maria Julieta V Peters, Klaus Garland, Suzanne M Szarewski, Anne Poppe, Willy AJ Romanowski, Barbara Schwarz, Tino F Tjalma, Wiebren AA Bosch, F Xavier Bozonnat, Marie-Cecile Struyf, Frank Dubin, Gary Rosillon, Dominique Baril, Laurence BMC Infect Dis Research Article BACKGROUND: More information is needed about time between sexual initiation and human papillomavirus (HPV) infection and development of cervical precancer. METHODS: The objectives were to investigate the time between first sexual activity and detection of first cervical HPV infection or development of first cervical intraepithelial neoplasia (CIN), and associated factors in women from the double-blind, multinational, 4-year PATRICIA trial. PATRICIA enroled women aged 15-25 years with no more than 6 lifetime sexual partners. Women were randomized 1:1 to the HPV-16/18 AS04-adjuvanted vaccine or to control, but only women from the control arm who began sexual intercourse during the study or within 6 months before enrolment, and had no HPV infection detected before the recorded date of their first sexual intercourse, were included in the present analysis. The time between onset of sexual activity and detection of the first cervical HPV infection or development of the first CIN lesion was analyzed using Kaplan-Meier and univariate and multivariable Cox proportional-hazards models. RESULTS: A total of 9337 women were enroled in the control arm of PATRICIA of whom 982 fulfilled the required inclusion criteria for analysis. A cumulative total of 28%, 44%, and 62% of the subjects had HPV infection within 12, 24, and 48 months, respectively. The overall incidence rate was 27.08 per 100 person-years. The most common oncogenic types associated with 6-month persistent infection were HPV-16 (incidence rate: 2.74 per 100 person-years), HPV-51 (2.70), HPV-52 (1.66), HPV-66 (1.14), and HPV-18 (1.09). Increased infection risk was associated with more lifetime sexual partners, being single, Chlamydia trachomatis history, and duration of hormone use. CIN1+ and CIN2+ lesions were most commonly associated with HPV-16, with an overall incidence rate of 1.87 and 1.07 per 100 person-years, respectively. Previous cervical HPV infection was most strongly associated with CIN development. CONCLUSIONS: More than 25% of women were infected with HPV within 1 year of beginning sexual activity. Without underestimating the value of vaccination at older ages, our findings emphasize its importance before sexual initiation. TRIAL REGISTRATION: clinicaltrials.gov: NCT00122681. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0551-y) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-30 /pmc/articles/PMC4251672/ /pubmed/25927224 http://dx.doi.org/10.1186/s12879-014-0551-y Text en © Castellsagué et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Castellsagué, Xavier Paavonen, Jorma Jaisamrarn, Unnop Wheeler, Cosette M Skinner, S Rachel Lehtinen, Matti Naud, Paulo Chow, Song-Nan Del Rosario-Raymundo, Maria Rowena Teixeira, Julio C Palmroth, Johanna de Carvalho, Newton S Germar, Maria Julieta V Peters, Klaus Garland, Suzanne M Szarewski, Anne Poppe, Willy AJ Romanowski, Barbara Schwarz, Tino F Tjalma, Wiebren AA Bosch, F Xavier Bozonnat, Marie-Cecile Struyf, Frank Dubin, Gary Rosillon, Dominique Baril, Laurence Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial |
title | Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial |
title_full | Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial |
title_fullStr | Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial |
title_full_unstemmed | Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial |
title_short | Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial |
title_sort | risk of first cervical hpv infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled patricia trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251672/ https://www.ncbi.nlm.nih.gov/pubmed/25927224 http://dx.doi.org/10.1186/s12879-014-0551-y |
work_keys_str_mv | AT castellsaguexavier riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT paavonenjorma riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT jaisamrarnunnop riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT wheelercosettem riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT skinnersrachel riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT lehtinenmatti riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT naudpaulo riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT chowsongnan riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT delrosarioraymundomariarowena riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT teixeirajulioc riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT palmrothjohanna riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT decarvalhonewtons riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT germarmariajulietav riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT petersklaus riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT garlandsuzannem riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT szarewskianne riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT poppewillyaj riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT romanowskibarbara riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT schwarztinof riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT tjalmawiebrenaa riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT boschfxavier riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT bozonnatmariececile riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT struyffrank riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT dubingary riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT rosillondominique riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT barillaurence riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial AT riskoffirstcervicalhpvinfectionandprecancerouslesionsafteronsetofsexualactivityanalysisofwomeninthecontrolarmoftherandomizedcontrolledpatriciatrial |